Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
With a market cap of 93.62B, Moderna(MRNA) trades at $230.82. The stock has a price-to-earnings ratio of -32.62.
On 2026-11-13, Moderna(MRNA) stock traded between a low of $229.69 and a high of $247.73. Shares are currently priced at $230.82, which is +0.5% above the low and -6.8% below the high.
Moderna(MRNA) shares are trading with a volume of 7.02M, against a daily average of 10.83M.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $280.80 at its peak.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $280.80 at its peak.
MRNA News
BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy. BioNTech has multiple catalysts that could generate a rally of 35% for the stock....
MRNA pioneer Moderna (MRNA -2.63%) stock tumbled more than 6% in early trading Thursday before clawing its way back to a 2% loss as of 11:50 a.m. ET. The reason...
...
Analyst ratings
59%
of 27 ratingsMore MRNA News
Moderna Inc. (NASDAQ:MRNA) on Thursday revealed its next growth phase during its 2026 Analyst Day, emphasizing the expansion of its mRNA platform into multiple...
Moderna (MRNA) on Thursday announced plans to position its biomanufacturing facility in Massachusetts as a global supply site for its much-anticipated cancer va...
The company said, “Moderna’s (MRNA) strategy is built on an integrated mRNA platform combining mRNA science, delivery technologies and manufacturing capabilitie...
The company said, “Manufacturing is a core component of Moderna’s (MRNA) integrated mRNA platform, supporting commercial vaccine supply, strategic partnerships...
Moderna (MRNA) outlined the next phase of growth at its 2026 Analyst Day, highlighting how more than a decade of investment in the Company’s mRNA platform has e...
Moderna (MRNA) expects 2026 revenue growth of 15% to 25%, compared with the original outlook of up to 10%, and is on track to achieve approximately 10 percentag...
MSCI (MSCI) has announced its November 2026 Equity Index Review, with changes across its U.S. equity indexes scheduled to take effect after the close of Novembe...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.